What systemic treatment do you recommend for an incidentally discovered IC2 high grade serous fallopian tube carcinoma in the setting of recent adjuvant paclitaxel administration for a non-gynecologic cancer?
Fallopian tube cancer discovered during prophylactic hysterectomy + BSO for BRCA mutation status with incomplete surgical staging. Patient received 12 weeks of weekly paclitaxel as adjuvant therapy for stage 1 breast cancer less than one year ago.
Community PollStarted
What systemic treatment do you recommend for an incidentally discovered fallopian tube cancer in the setting of prior paclitaxel administration for a non-gynecologic cancer?
22 physicians have voted
Join Mednetto vote and see how they answered.